Catalina Fandino had a recurrence more than a year after her Whipple, but she qualified for daraxonrasib, which has changed her current path. bit.ly/4ddqERy
bit.ly
Updating My Story: Daraxonrasib Is Making a Difference
Catalina Fandino had a recurrence more than a year after her Whipple, but she qualified for daraxonrasib, which has changed her current path.